Bio Essence Corporation
BIOE
$0.0937
$0.00272.97%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 127.77% | -253.70% | 85.75% | -281.04% | 24.18% |
| Total Depreciation and Amortization | -66.67% | -80.00% | 100.99% | -99.39% | -98.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -90.76% | 105.32% | -75.00% | 1,853.65% | 7.35% |
| Change in Net Operating Assets | -8.29% | 456.01% | 1,122.82% | 397.71% | 211.94% |
| Cash from Operations | 996.73% | 84.79% | 307.30% | 203.57% | 106.24% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 99.89% | -- | -- |
| Total Debt Issued | 1,561.82% | 81.44% | -- | -155.55% | -101.84% |
| Total Debt Repaid | -82,600.00% | -3,212.37% | -1,278.85% | -1,138.36% | 99.44% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -- | -- |
| Cash from Financing | -2,793.10% | -85.61% | -254.62% | -196.78% | -102.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -100.00% | -- | -28,700.00% | 4,160.00% | 2,275.00% |